Literature DB >> 3260145

A monoclonal antibody for the specific diagnosis of plague.

J E Williams, M K Gentry, C A Braden, G L Tyndal, P L Altieri, S Berman, D M Robinson.   

Abstract

A stable mouse-cell hybridoma was obtained that secretes an IgA monoclonal antibody reactive with the fraction 1 (F1) envelope antigen of Yersinia pestis. Titres of the antibody typically ranged from 1:32 768 to 1:65 536 in mouse ascitic fluids.The monoclonal antibody formed a line of precipitation when run against F1 antigen in Ouchterlony gel diffusion tests. In tests of 235 strains of Y. pestis, lines of identity occurred between the precipitates formed with a solution of purified F1 antigen and the F1 antigen produced by the plague strains. No precipitates formed for 65 strains that were incapable of elaborating F1 antigen. Specificity of the monoclonal antibody for strains of Y. pestis producing F1 was also indicated by negative results for 50 yersinia strains other than Y. pestis tested by an ELISA that used the antibody to capture antigen.Experiments to determine the shelf-life of the antibody were conducted over 3-4 years. When the monoclonal antibody was freeze-dried in vials, titre was retained for three years when the vials were stored at -70 degrees C but only for two months when they were stored at ambient temperatures. When the antibody was freeze-dried in wells of ELISA plates, sensitivity of the plates for capture of F1 antigen was preserved for four years when the plates were stored at -70 degrees C compared with two weeks for plates stored at room temperature. When a solution of the antibody was sealed in wells of ELISA plates and refrigerated at 4 degrees C, reactivity of the antibody and sensitivity of the plates were retained for a year.Alternatives for the application of this monoclonal antibody in ELISA and other plague diagnostic procedures are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260145      PMCID: PMC2491117     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  10 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  An unusual strain of Pasteurella pestis isolated from a fatal human case of plague.

Authors:  C C WINTER; W B CHERRY; M D MOODY
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

3.  Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies.

Authors:  M K Gentry; E A Henchal; J M McCown; W E Brandt; J M Dalrymple
Journal:  Am J Trop Med Hyg       Date:  1982-05       Impact factor: 2.345

4.  Comparison of passive haemagglutination and enzyme-linked immunosorbent assay for serodiagnosis of plague.

Authors:  J E Williams; L Arntzen; D M Robinson; D C Cavanaugh; M Isaäcson
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

5.  Hybrid plasmacytoma production: fusions with adult spleen cells, monoclonal spleen fragments, neonatal spleen cells and human spleen cells.

Authors:  R H Kennett; K A Denis; A S Tung; N R Klinman
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

6.  Solid-phase radioimmunoassay for detection of plague antigen in animal tissue.

Authors:  M E Soergel; F L Schaffer; H F Blank
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

7.  Use of an enzyme-linked immunosorbent assay to measure antigenaemia during acute plague.

Authors:  J E Williams; M K Gentry; C A Braden; F Leister; R H Yolken
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

8.  Analysis of parameters affecting the solid phase radioimmunoassay quantitation of antibody to meningococcal antigens.

Authors:  W D Zollinger; J M Dalrymple; M S Artenstein
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

9.  Potential for rat plague from nonencapsulated variants of the plague bacillus (Yersinia pestis).

Authors:  J E Williams; D C Cavanaugh
Journal:  Experientia       Date:  1984-07-15

10.  Application of enzyme immunoassays for the confirmation of clinically suspect plague in Namibia, 1982.

Authors:  J E Williams; L Arntzen; G L Tyndal; M Isaäcson
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

  10 in total
  3 in total

1.  Use of ELISA to reveal rodent infections in plague surveillance and control programmes.

Authors:  J E Williams
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Detection of Yersinia pestis fraction 1 antigen with a fiber optic biosensor.

Authors:  L K Cao; G P Anderson; F S Ligler; J Ezzell
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

3.  Development of a dual antigen lateral flow immunoassay for detecting Yersinia pestis.

Authors:  Derrick Hau; Brian Wade; Chris Lovejoy; Sujata G Pandit; Dana E Reed; Haley L DeMers; Heather R Green; Emily E Hannah; Megan E McLarty; Cameron J Creek; Chonnikarn Chokapirat; Jose Arias-Umana; Garett F Cecchini; Teerapat Nualnoi; Marcellene A Gates-Hollingsworth; Peter N Thorkildson; Kathryn J Pflughoeft; David P AuCoin
Journal:  PLoS Negl Trop Dis       Date:  2022-03-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.